New Bill Aims to Curb Prescription Drug Diversion and Abuse
Legislation aimed to improve enforcement efforts related to prescription drug diversion and abuse has been introduced to the US House of Representatives. If approved, the “Ensuring Patient Access and Effective Drug Enforcement Act of 2013” would amend the Controlled Substances Act by requiring companies registered with Drug Enforcement Administration (DEA) to ensure employees with access to controlled substances meet criminal background checks and drug testing requirements. The new bill would also require the formation of a Combating Prescription Drug Abuse Working Group consisting of 20 members, including representatives from DEA, FDA, National Drug Control Policy, patients, pharmacies, and manufacturers. The bill has been referred to the Energy and Commerce Committee and to the Judiciary Committee.quoted from here
No comments:
Post a Comment